MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Stimulation induced dystypia after pallidal deep brain stimulation

    J. Wong, M. Armstrong, L. Almeida, M. Okun, I. Malaty (Gainesville, FL, USA)

    Objective: _ Background: Typing on a keyboard requires complex collaboration between visuospatial procedural memory, language and motor function [1,2]. The impaired ability to type, independent…
  • MDS Virtual Congress 2020

    Weeding Through the Haze: A Survey on Cannabis Use Among People with Parkinson’s Disease

    M. Feeney, B. Kluger, A. Stoessl, D. Bega, S. Gilbert, A. Hosang, E. Ogren, K. Schroeder, C. Evers, J. Beck (New York, NY, USA)

    Objective: To identify themes in cannabis use among people with Parkinson’s disease to inform medical recommendations and the design of future clinical trials. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Association of environmental exposure to herbicides, fungicides, and insecticides used in agriculture with incidence of Parkinson’s disease in the French general population

    L. Perrin, J. Spinosi, L. Chaperon, D. Jezewski-Serra, M. El Yamani, F. Moisan, A. Elbaz (Villejuif, France)

    Objective: To examine the association of exposure to categories of pesticides (H-I-F) with PD incidence in the French general population. Background: Environmental exposure to pesticides…
  • MDS Virtual Congress 2020

    A Korean first case of Boucher-Neuhäuser syndrome with two novel mutations of PNPLA6 gene

    E. Chung, S. Kim (Busan, Republic of Korea)

    Objective: To report a patient who presented with hypogonadotropic hypogonadism, chorioretinal dystrophy, and cerebellar ataxia. He has 2 missense variant mutations of PNPLA6. Background: Boucher-Neuhäuser…
  • MDS Virtual Congress 2020

    Longitudinal Utility of the Montreal Cognitive Assessment and Mini Mental State Exam in Huntington’s disease (HD)

    I. Beltran-Najera, J. Corey-Bloom, C. Snell, A. Smirnova, P. Gilbert (San Diego, CA, USA)

    Objective: Neuropsychological assessments are useful tools for examining and tracking cognitive impairment in individuals with neurological disorders; however, a full neuropsychological battery is not realistic…
  • MDS Virtual Congress 2020

    The genetic study of hereditary chorea in Kazakhstan

    R. Kaiyrzhanov, N. Zharkinbekova, A. Aitkulova, V. Akhmetzhanov, Z. Jarmukhanov, H. Houlden (London, United Kingdom)

    Objective: To analyze the genetic background of hereditary chorea in Kazakhstani population. Background: Hereditary chorea (HC) is a group of inherited movement disorders presenting with…
  • MDS Virtual Congress 2020

    Biological and Clinical Manifestations of Huntington’s disease in Gene Carriers Very Far from Predicted Onset: The Young Adult Study

    P. Zeun, R. Scahill, K. Osborne-Crowley, E. Johnson, S. Gregory, C. Parker, J. Lowe, A. Nair, C. O'Callaghan, C. Langley, M. Papoutsi, P. McColgan, C. Estevez-Fraga, K. Fayer, H. Wellington, F. Rodrigues, L. Byrne, A. Heselgrave, H. Hyare, C. Sampaio, H. Zetterberg, H. Zhang, E. Wild, G. Rees, T. Robbins, B. Sahakian, D. Langbehn, S. Tabrizi (London, United Kingdom)

    Objective: To perform a deep phenotyping of a Huntington’s Disease (HD) cohort further from onset than previously studied to establish when disease related markers first…
  • MDS Virtual Congress 2020

    MRI findings in a 65-year old female with movement disorder

    X.Y Li, L. Wang, X.H Wan (Beijing, China)

    Objective: We reported a 65-year-old woman presented with dysarthria, chorea, facial and neck dystonia. Background: Aceruloplasminemia is an autosomal recessive disorder characterized by progressive neurodegeneration,…
  • MDS Virtual Congress 2020

    Oral treatment of the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS) with the neuro-inflammation inhibiting compound PRI-003

    J. Post-Schulz, A. Schaffrath, A. Willuweit, D. Willbold, J. Kutzsche (Jülich, Germany)

    Objective: Demonstration of beneficial effects of neuro-inflammation inhibition for the treatment of amyotrophic lateral sclerosis (ALS). Background: Neuro-inflammation and immune-inflammatory processes are characteristics of the…
  • MDS Virtual Congress 2020

    Undiagnosed Neuropathology In Fallers: Findings from a 10-year Autopsy Series

    C. Fearon, C. Hunt, J. Lorigan, A. Beausang, J. Cryan, M. Farrell, F. Brett (Dublin, Ireland)

    Objective: To examine the range of neuropathology in people who die from a fall compared to those who die in alternate circumstances. Background: The neural…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley